First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection

  First Warning Systems and Unicorp Biotech International Strategic Partner
            Letter of Intent Signed Breast Cancer Early Detection

PR Newswire

RENO, Nev., Dec. 12, 2012

RENO, Nev., Dec. 12, 2012 /PRNewswire/ --First Warning Systems, Inc.
announced a Letter of Intent with Budapest, Hungary, European Union based
medical products marketing partner, UniCorp Biotech. "We look forward to
productive developments regarding the regulatory advise, marketing and
distribution resources of UniCorp Biotech", says Jim Holmes, Chairman and CEO
of First Waning Systems. "The Letter of Intent outlines a mutually beneficial
process for defining how the capabilities of UniCorp Biotech can partner with
First Warning", adds Dr. Laszlo Horvath, CEO.

"We are planning for the CE Mark process early in 2013 to be followed by
clinical validation and market entry of the First Warning Systems in select
European markets", says Matt Benardis, First Warning Operations Manager.
"Discussions with Dr. Horvath regarding UniCorp Biotech services to expedite
certification and time-to-market have been encouraging", adds Benardis.

About First Warning Systems Process
Temperature readings of breast tissue create a dynamic cell chaos profile
using 9,600 points of dynamic data which are correlated to dysfunctional
circadian genes. Multiple bioinformatics algorithms compare the circadian gene
protein profiles to identify breast tissue abnormalities at different stages
of development of disturbed breast cancerous cells. FWS delivers a report to
the primary care physician with industry leading 90% accuracy. The FWS process
is the only detection process that identifies abnormalities before a tumor
presents and can be used by a primary care physician.

About First Warning Systems
First Warning Systems, (FWS) founded in 2008, is based in Reno, NV. FWS's
principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO).
FWS holds the exclusive development, manufacturing and marketing worldwide
license from Lifeline, to commercialize the intellectual property. The FWS
product line is a device and process that detects breast tissue abnormalities
leading to health risk assessment and management and potentially, breast
cancer. Three clinical trials with over 650 participants have achieved proof
of concept and superior outcomes when compared to other diagnostic protocols.
FWS is planning a final, limited clinical trial and a 510k device
classification to validate the fourth generation of the FWS product. FWS is
preparing to apply for a Euro CE Mark to market in the UK, EU and Russia
markets. See FWS' video, "Breast Cancer Tumor Progression" at
www.firstwarningsystems.com. For more information, contact: Abbi Whittaker,
The Abbi Agency. (775) 323-2977, abbi@theabbiagency.com

About Unicorp Biotech
UniCorp Biotech was founded at the turn of the century. The owners desire to
play a key role in the changing health care system of Europe in the area of
quick and easy home access. Our company also manages (preparations, ethical
permissions, monitoring) CRO projects within and outside of the European
Union. We have the privilege to welcome among our customers many multinational
companies acting in health care and distribution, such as Merck-Serono,
Alexion, Gedeon Richter, PhamaNord, PhoenixPharma, HungaroPharma, Krka,
Yamanouchi, Pliva, Tesco, Rossmann, Schlecker, Hungarian Military, National
Police Headquarters. Our products are available in most pharmacies throughout
Hungary and in some CEE countries. Since January of 2006, we have been the
official Hungarian representatives of the Berlin-based Bayer Dermatology.
UniCorp Biotech also provides information and preventive help for women,
infants and Hungarians needing to be more informed, www.infertility.hu. &
www.feminin.hu & www.abstinentia.huprovide assistance to those dealing with
drug or other dependencies. For more information, contact: Dr. Laszlo Horvath,
CEO, UniCorp Biotech Kft, H-1126 Budapest, Toth Lorincu.41., Hungary, Tel.:
+36-1-393-5050, Fax: +36-1-393-5055.

SOURCE First Warning Systems, Inc.

Website: http://www.firstwarningsystems.com
 
Press spacebar to pause and continue. Press esc to stop.